Six Key Features of Affinité's P4SPR

Here is how P4SPR helps accelerating research and educating the next generation of scientists

Direct Detection

Core technology capable of direct detection in complex samples such as serum, plasma and blood for little to no sample preparation

Multi-Channel Testing

4-channel design providing background-corrected, triplicate sample data for precise and accurate results every time


Proprietary optical design packaged in a compact, book-size device for robustness and low maintenance

User Friendly

Takes minutes to learn so you can quickly control and design your own tests and assays


Easy in-line integration with MS or HPLC with possible integration of spectroscopy and electrochemistry


Access deep knowledge and expertise in deploying SPR to address real-life analytical and bioanalytical challenges

Next Generation SPR: Simplified Sensors

Affinité is expanding SPR into applications requiring small, lowplex sensors for rapid monitoring of targets such as organic compounds, proteins and even new materials. Here are a few examples.

    Explosives Residues in Ground Water: P4SPR deployed on the field to detect small organic explosives residues at ppb levels in water

    Immunogenicity Assay to Detect ABAsDevelopment of integrated SPR/ELISA for anti-drug antibodies (ABAs) detection in clinical samples

    Plasmonic Materials Development: SPR characterization of microhole arrays for combined SPR/LSPR benefits in conventional SPR

    Immunoassay to Detect a Cytokine: A selectivity assay to characterize EBI3/IL-6 binding to strengthen a biological chemistry study

    Lowplex Small Ligand Screening: Affinity measurements of small ligand binding to a scavenger receptor for biosensing characterization


    A team focused on the commercialization of demand-driven innovations
    Ludovic Live

    Ludovic Live


    Navigating in business and science, Dr. Live is a chemistry trained, former policy advisor with startup experience. Key experiences include working on Advanced Manufacturing initiatives with Ontario and working with a medical device startup that raised over $50M in funding.

    Jean-François Masson

    Jean-François Masson


    Expert on surface plasmon resonance technologies, instrumentation and analytical chemistry, Dr. Masson is a full professor of Chemistry at the Université de Montréal (Canada).

    Joelle Pelletier

    Joelle Pelletier

    Vice President, Research

    Expert on biodetection and protein engineering integrating protein structure determination, Dr. Pelletier is co-director of PROTEO and professor of Chemistry and adjunct professor of Biochemistry at UdeM.

    Sandy Zhao

    Sandy Zhao

    Field Application Specialist

    Dr. Zhao is an expert in process development in the drug manufacturing and contract analytical services. Dr. Zhao helps a broad base of customers as she is fluent in French, English and Mandarin.

    Michael Atkin

    Michael Atkin

    Business Advisor and Board Member

    Mr. Atkin is CEO of Gladius Pharmaceuticals, a biotechnology firm developing novel drugs to treat life-threatening, multi-drug-resistant bacterial infections. He has many years of experience in advancing early stage life sciences products and technologies towards commercialization.

    Philippe Masson

    Philippe Masson

    Engineering Advisor AND BOARD MEMBER

    Mr. Masson is Director Software Research & Development for AV&R. In addition to his deep knowledge in machine vision and robotics, Mr Masson works with international clients to focus technological development according to clients’ needs.

    Follow us on Twitter @Affiniteinstrmt

    Mentorship and Academic Support

    Give us a shout

    We are here to help you

    We are located in:

    Montréal (Headquarter) - 11647 rue Edith-Serei, Montreal, Quebec, H1E 0V7, Canada
    Toronto - 5233 Dundas St. West, unit 1526, Toronto, Ontario, M9B 6M1, Canada

    Let's talk

    Ludovic Live, Ph.D.
    Chief Executive Officer and Co-founder

    Contact Us